✦ LIBER ✦

Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer Program

✍ Scribed by See, William A.; Wirth, Manfred P.; McLeod, David G.; Iversen, Peter; Klimberg, Ira; Gleason, Donald; Chodak, Gerald; Montie, James; Tyrrell, Chris; Wallace, D.M.A.; Delaere, Karl P.J.; Vaage, Sigmund; Tammela, Teuvo L.J.; Lukkarinen, Olavi; Persson, Bo-Eric; Carroll, Kevin; Kolvenbag, Geert J.C.M.

Book ID: 121904028
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 461 KB
Volume: 168
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)64652-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bicalutamide as immediate therapy either

Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. See WA, Wirth MP, McLeod DG, Iversen P, Klimberg I, Gleason D, Chodak G, Montie J, Tyrrell C, Wallace DM, Delaere KP, Vaage S, Tammela TL, Lukkarinen O, Persson BE, Carroll K, Kolvenbag GJ; Casodex Early Prostate Cancer Trialist Group, Medical College of Wisconsin, Milwaukee, WI: J Urol 2002;168:429–435

✍ Donald L Trump 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 23 KB

A Randomised Comparison of Bicalutamide

A Randomised Comparison of Bicalutamide (‘Casodex’) 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer: First Report from the Scandinavian Prostatic Cancer Group Study No. 6

✍ P Iversen; T.L.J Tammela; S Vaage; O Lukkarinen; P Lodding; T Bull-Njaa; J Viita 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Bicalutamide (Casodex) 150 mg as immedia

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

✍ M Wirth; C Tyrrell; M Wallace; K.P Delaere; M Sánchez-Chapado; J Ramon; J Hether 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Bicalutamide (‘Casodex’) 150 mg as

Bicalutamide (‘Casodex’) 150 mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

✍ Chris J. Tyrrell; Heather Payne; William A. See; David G. McLeod; Manfred P. Wir 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 245 KB

BICALUTAMIDE 150 MG IN ADDITION TO STAND

BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS

✍ WIRTH, MANFRED P.; SEE, WILLIAM A.; McLEOD, DAVID G.; IVERSEN, PETER; MORRIS, TO 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 220 KB

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS

BICALUTAMIDE (150 MG) VERSUS PLACEBO AS IMMEDIATE THERAPY ALONE OR AS ADJUVANT TO THERAPY WITH CURATIVE INTENT FOR EARLY NONMETASTATIC PROSTATE CANCER: 5.3-YEAR MEDIAN FOLLOWUP FROM THE SCANDINAVIAN PROSTATE CANCER GROUP STUDY NUMBER 6

✍ IVERSEN, PETER; JOHANSSON, JAN-ERIK; LODDING, PÄR; LUKKARINEN, OLAVI; LUNDMO, PE 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 334 KB